이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

NAVA 인공호흡이 선천성 심장병이 있는 어린이의 뇌 산소화 및 관류에 미치는 영향

2026년 9월 15일 업데이트: Dr Guillaume Emeriaud, St. Justine's Hospital

Positive intra-thoracic pressures induced by mechanical ventilation can negatively impact right heart hemodynamics by restricting systemic venous return and increasing right ventricular afterload. These consequences may be detrimental in patients with a restrictive right ventricular physiology and in patients with single ventricle physiology. NAVA (Neurally Adjusted Ventilatory Assist) ventilation decreases intra thoracic pressures compared to conventional ventilation modes. Brain perfusion is both a hemodynamic indicator and a prognostic factor in cardiac postoperative care. Diffuse Correlation Spectroscopy (DCS) coupled with Near Infrared Spectroscopy (NIRS) is a new technology that allows monitoring, in addition to brain tissue oxygenation, changes in brain blood flow.

This physiological study aims to evaluate the impact of NAVA mode ventilation on cerebral and systemic hemodynamics in post-operative cardiac surgery patients with preload dependant right ventricle or with passive venous return to the lungs . This prospective cross-over study will include 30 patients.

Once stabilized in intensive care, patients will undergo 2 periods of ventilation in conventional mode and NAVA mode.

For each period the following information will be collected: changes in cerebral blood flow and cerebral oxygenation, hemodynamic parameters including cardiac output and oxygen transport and ventilatory parameters.

연구 개요

상세 설명

  1. Scientific context

    In post-operative cardiac surgery, invasive ventilation is often necessary, but the induced positive intra thoracic pressures can be detrimental to hemodynamics via several mechanisms: decrease in venous return, increase in pulmonary vascular resistance and increase in the afterload of the right ventricle. This effect is particularly problematic in patients with a restrictive right ventricle, who are preload dependent, and in patients with cavo pulmonary connections for single ventricle palliation. In these patients, decreasing ventilator positive pressure improves cardiac output and cerebral oxygenation. However, very early extubation is not always possible or safe, and it is therefore essential to optimize mechanical ventilation in order to minimize its hemodynamic consequences.

    In adults, ventilation in NAVA (Neurally Adjusted Ventilatory Assist) mode, regardless of the level of assistance, allows the preservation of intra thoracic pressure variations characteristic of spontaneous ventilation and limits the impact of ventilation on right ventricular ejection. In children, inspiratory and mean pressures are also lower in NAVA compared to conventional ventilation.

    Assessment of brain oxygenation and perfusion in cardiovascular resuscitation is important both as a hemodynamic parameter and as a neurological prognostic factor. An innovative non-invasive tool, Diffuse Correlation Spectroscopy coupled with Near Infrared Spectroscopy (DCS-NIRS), allows the non-invasive evaluation of both cerebral oxygenation and variations in cerebral blood flow.

  2. Hypothesis and objectives

    The hypothesis is that the NAVA ventilation mode, which generates lower intra thoracic pressures than conventional ventilation modes, will improve cerebral hemodynamics, cardiac output, and oxygen transport of at-risk patients in the post-operative cardiac surgery setting compared with conventional ventilation.

    Main objective:

    In pediatric patients following cardiac surgery with risk of right ventricular diastolic dysfunction or passive pulmonary venous return (including Glenn, hemi-Fontan, Fontan, and Tetralogy of Fallot surgery), investigators will evaluate the impact of NAVA ventilation on:

    • cerebral perfusion: cerebral blood flow (mm2/s) measured by DCS.
    • cerebral oxygenation: cerebral tissue saturation (%) and regional cerebral O2 extraction (OEF, measured by NIRS-DCS).

    Secondary objective:

    In pediatric post-operative cardiac surgery patients with risk of restrictive right ventricle or passive pulmonary venous return (including Glenn, hemi-Fontan, Fontan, and Tetralogy of Fallot type surgery), investigators will compare the impact of conventional ventilation to NAVA mode on:

    • Brain regional O2 consumption extracted from NIRS-DCS measurements
    • Systemic hemodynamics, including cardiac index, lactate level, central venous oxygen saturation (ScvO2), and oxygen transport
    • Ventilation parameters
    • Comfort as measured by the COMFORT behavioural scale
  3. Methods

This is a prospective cross-over, single-center, physiological study to be conducted in the Pediatric Intensive Care Unit of CHU Sainte Justine (Montreal, Canada).

Two periods of 30 to 60 minutes in each of 2 ventilation modes will be compared: conventional ventilation mode (as prescribed by the treating team) and NAVA mode.

On admission to the PICU postoperatively, study patients will be fitted with a naso-gastric NAVA probe.

Before performing any study measurements, investigators will wait for patient stabilization, which is defined by:

  • absence of hemodynamically significant bleeding
  • stabilization of the ventilation parameters
  • stable inotrope dose

Study period ventilation will be set as follows:

  • conventional ventilation: ventilation as prescribed by the treating team will be continued. Usually, ventilation is in PRVC (pressure regulated volume control) mode with a tidal volume between 5 and 8 mL/kg, a peep between 4 and 5, a respiratory rate to aim for normocapnia, and FiO2 to aim for PaO2 between 100 and 150 mmHg.
  • NAVA Mode: NAVA level setting to target an Edi level between 3 and 20 V, tidal volume between 5 and 7 mL/kg, and no respiratory distress on physical examination. The trigger will be set at 0.5 V. The maximum pressure will be limited to 30 cmH2O. The PEEP level will not be changed from that prescribed by the treating physician.

To facilitate comparability of brain flow and oxygenation measurements, FiO2, NO concentration, inotrope dose, and sedation will be kept as stable as possible during these periods, at the discretion of the treating physician. Similarly, if possible, blood transfusions will not be administered during the study period.

During the two periods of ventilation, the following parameters will be recorded continuously:

  • ventilatory parameters: ventilator parameters according to the set mode: peak inspiratory pressure, mean airway pressure, PEEP, tidal volume, total and spontaneous minute ventilation, Edi level, FiO2, exhaled CO2 via volumetric capnography.
  • hemodynamic parameters: heart rate (HR), mean arterial pressure, systolic, diastolic, central venous pressure (CVP), left atrial pressure (LAP), type and dose of vasoactive medications received with calculation of the vasoactive-inotropic score.

In the second half of each period, investigators will perform:

  • a central arterial and venous blood gas and an arterial lactate measurement.
  • a measurement of cerebral blood flow by diffuse correlation spectroscopy and a measurement of cerebral regional tissue saturation and oxygen extraction. These measurements are done non-invasively and painlessly by applying a probe to the child's forehead for approximately 20 minutes.
  • a limited cardiac ultrasound for the calculation of cardiac output (CO).
  • calculation of urine output during the ventilation period.

In addition, for each patient, the following information will be collected:

  • age at the time of surgery
  • cardiac diagnosis
  • existence and quantification of aorto-pulmonary collaterals
  • preoperative medications
  • operative details: surgical procedure, duration of cardiopulmonary bypass, aortic cross-clamp duration, inotropes administered (and maximum dose).
  • result of the postoperative trans-esophageal cardiac echo (cardiac function, evaluation of repair, presence of residual anatomic lesions)
  • arterial and venous blood gases, lactate and haemoglobin levels prior to study ventilation periods
  • time interval between the end of cardiopulmonary bypass and the start of study measurements

The variables will be expressed in terms of mean standard deviation or median (interquartile), depending on the nature of their distribution. Because of the sample size, analysis of the differences between t variables during the 2 modes of ventilation will be done using the non-parametric Wilcoxon test (all the variables studied are of the continuous type). A value of p <0.05 will be considered significant.

For the calculation of sample size, investigators estimated, using the study by Huang et al, that the standard deviation of brain saturation would be 6%, and that the expected difference between the 2 ventilation modes would be at least 6%. To reach a power of 90% with an alpha risk set at 0.05, a minimum of 24 patients is required. Given the risk of loss of sight (e.g. technical difficulty in obtaining the main variable) and due to the heterogeneity of the patient population, we decided to aim to include 30 patients.

Note that no power calculation based on the variations in cerebral blood flow measured in spectroscopy was performed, because there was no preliminary data on the subject.

Approval from the Research Ethics Committee of Sainte Justine University Hospital and the University Medical Affairs Department was obtained. Written consent will be required from the parents.

연구 유형

중재적

등록 (실제)

30

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • Quebec
      • Montreal, Quebec, 캐나다, H3T 1C5
        • St. Justine's Hospital

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

1일 (어린이, 성인)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  1. admission to the pediatric intensive care unit:

    • after Glenn, Fontan, Fallot Tetralogy surgery
    • or after other types of surgery with risk of post-operative occurence of right ventricular failure or low lung output
  2. invasive ventilation scheduled for at least 2 hours after admission

Exclusion Criteria:

  • Contraindication to placement of a nasogastric NAVA tube
  • History of significant focal brain injury (infarction or hemorrhage)
  • Bilateral phrenic paralysis
  • Extubation in operating room or planned to be within the hour,
  • Patient with open chest, uncontrolled shock, need for neuromuscular blockade. Note that for these criteria, the patient may become eligible when these criteria are resolved.
  • Patients for whom an acute care limitation order is in place.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 다른
  • 할당: 무작위화되지 않음
  • 중재 모델: 크로스오버 할당
  • 마스킹: 없음(오픈 라벨)

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Brain perfusion
기간: 5 minute period at the end of each 60-minute ventilatory periods

cerebral blood flow measured with diffuse correlation spectroscopy (mm2/s)

5 minute period at the end of each 60-minute ventilatory periods
Brain oxygenation
기간: median value of the continuous measurement during each of the two 60-minute ventilatory periods

cerebral tissue saturation measured with near-infrared spectroscopy (%)

median value of the continuous measurement during each of the two 60-minute ventilatory periods
Brain oxygen extraction
기간: 5 minute period at the end of each 60-minute ventilatory periods

Cerebral tissue oxygen extraction measured with near-infrared spectroscopy (%)

5 minute period at the end of each 60-minute ventilatory periods

2차 결과 측정

결과 측정
측정값 설명
기간
Brain regional oxygen consumption
기간: 5 minute period at the end of each 60-minute ventilatory periods

Cerebral tissue oxygen consumption measured with near-infrared spectroscopy

5 minute period at the end of each 60-minute ventilatory periods
Cardiac output
기간: in the 10 minute period at the end of each 60-minute ventilatory periods

Cardiac output measured using sub aortic time-velocity integral measured on cardiac ultrasound

in the 10 minute period at the end of each 60-minute ventilatory periods
Cardiac index
기간: in the 10 minute period at the end of each 60-minute ventilatory periods

Cardiac index measured using sub aortic time-velocity integral measured on cardiac ultrasound

in the 10 minute period at the end of each 60-minute ventilatory periods
Oxygen transport
기간: in the 10 minute period at the end of each 60-minute ventilatory periods

According to the following calculation: 1.34 x hemoglobin x SaO2 + 0.0031 x PaO2

in the 10 minute period at the end of each 60-minute ventilatory periods
Mean airway pressure (cmH2O)
기간: median value of the continuous measurement during each of the two 60-minute ventilatory periods

Mean airway pressure (cmH2O) extracted from the ventilator every 30 seconds

median value of the continuous measurement during each of the two 60-minute ventilatory periods
Tidal volume
기간: median value of the continuous measurement during each of the two 60-minute ventilatory periods

extracted from the ventilator every 30 seconds

median value of the continuous measurement during each of the two 60-minute ventilatory periods
Respiratory rate
기간: median value of the continuous measurement during each of the two 60-minute ventilatory periods

extracted from the ventilator every 30 seconds

median value of the continuous measurement during each of the two 60-minute ventilatory periods
Minute ventilation
기간: median value of the continuous measurement during each of the two 60-minute ventilatory periods

extracted from the ventilator every 30 seconds

median value of the continuous measurement during each of the two 60-minute ventilatory periods
Electrical activity of the diaphragm
기간: median value of the continuous measurement during each of the two 60-minute ventilatory periods

extracted from the ventilator every 30 seconds

median value of the continuous measurement during each of the two 60-minute ventilatory periods
PaO2/FiO2 ratio
기간: Within the 10 minutes at the end of the two 60-minute ventilatory periods

Ratio calculated at the end of each ventilation period, based on arterial blood gas

Within the 10 minutes at the end of the two 60-minute ventilatory periods

기타 결과 측정

결과 측정
측정값 설명
기간
Patient comfort
기간: MEdian value within each of the two 60-minute ventilatory periods

Measured by the COMFORT Behavioural scale (ranges: 6-30, the lowest being the better)

MEdian value within each of the two 60-minute ventilatory periods

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: Guillaume Emeriaud, Dr, St. Justine's Hospital

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2020년 10월 5일

기본 완료 (실제)

2026년 2월 3일

연구 완료 (실제)

2026년 2월 3일

연구 등록 날짜

최초 제출

2020년 9월 27일

QC 기준을 충족하는 최초 제출

2020년 10월 2일

처음 게시됨 (실제)

2020년 10월 9일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 9월 21일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 9월 15일

마지막으로 확인됨

2026년 9월 1일

추가 정보

이 연구와 관련된 용어

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

미정

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다